ArticleStem cell research & therapy2018

Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight.

Flavia Bruna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.